- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Real Chemistry and Aktana Announce New Partnership
Partnership pairs Aktana’s Contextual Intelligence Engine with Real Chemistry’s data and creative campaign.
Real Chemistry, a global health innovation company, and Aktana, a pioneer in intelligent customer engagement for the global life sciences industry, today announced a partnership that will reimagine commercial strategy, engagement and execution. Pre-built integrations between the two companies’ solutions will translate Real Chemistry’s healthcare social data points from 3 million healthcare influencers and 160,000 healthcare providers (HCPs) and claims data into dynamic, actionable insights for life sciences sales, marketing and medical teams.
Through this partnership, life sciences companies will be equipped not only to identify the right HCPs, but also to predict the right engagement timing, content, channel, and next-best actions to help HCPs learn about new treatment options and improve patient care.
Read more about the new partnership here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
